Relatório global de análise do tamanho, quota e tendências do mercado de serviços de fertilidade – Visão geral do setor e previsão para 2031

Análise de mercado de serviços de fertilidade  

O mercado dos serviços de fertilidade está a testemunhar um crescimento robusto, impulsionado por uma combinação de taxas crescentes de infertilidade, avanços nas tecnologias de reprodução assistida (TARV) e uma crescente consciencialização sobre a saúde reprodutiva. Desenvolvimentos notáveis ​​neste sector incluem a integração de tecnologias de ponta, como os testes genéticos pré-implantacionais (PGT), que permitem o rastreio de embriões quanto a doenças genéticas, melhorando assim as taxas de sucesso da fertilização in vitro (FIV). Além disso, o mercado tem assistido a um aumento dos serviços de telemedicina, permitindo aos pacientes aceder a consultas e tratamentos de fertilidade a partir do conforto das suas casas. A crescente aceitação dos métodos de preservação da fertilidade, especialmente entre as mulheres mais jovens que desejam adiar o parto, está também a moldar o panorama do mercado. Além disso, as colaborações entre clínicas de fertilidade e empresas de biotecnologia estão a promover a inovação nos tratamentos de fertilidade, conduzindo a soluções personalizadas adaptadas às necessidades individuais. Com estes desenvolvimentos, o mercado dos serviços de fertilidade está preparado para um crescimento contínuo, respondendo às crescentes exigências dos pacientes e melhorando o ecossistema global de saúde reprodutiva.

Dimensão do mercado de serviços de fertilidade

A dimensão do mercado global de serviços de fertilidade foi avaliada em 20,24 mil milhões de dólares em 2023 e deverá atingir os 36,63 mil milhões de dólares até 2031, com um CAGR de 7,70% durante o período de previsão de 2024 a 2031. Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços e enquadramento regulamentar.

Tendências do mercado de serviços de fertilidade

“ Crescente procura de preservação da fertilidade”

O mercado dos serviços de fertilidade está a registar um crescimento significativo devido ao aumento das taxas de infertilidade e à crescente sensibilização para a saúde reprodutiva. Em particular, as tecnologias de reprodução assistida (TARV), como a fertilização in vitro (FIV), ganharam popularidade como soluções eficazes para os casais que lutam para conceber. Uma tendência notável no mercado é a crescente procura pela preservação da fertilidade, especialmente entre as mulheres que atrasam o parto por motivos profissionais ou pessoais. Por exemplo, muitas clínicas oferecem agora serviços de congelação de óvulos para ajudar as mulheres a manterem as suas opções reprodutivas. Além disso, os avanços nos testes genéticos e nas tecnologias de selecção de embriões estão a aumentar as taxas de sucesso, tornando a TARV mais apelativa. Como resultado, prevê-se que o mercado dos serviços de fertilidade se expanda ainda mais, com um maior investimento em soluções inovadoras que vão ao encontro das diversas necessidades dos doentes. Este crescimento reflecte uma mudança social mais ampla no sentido de dar prioridade à saúde reprodutiva e de fornecer aos indivíduos as ferramentas e o apoio de que necessitam para construir famílias.

Âmbito do relatório e segmentação do mercado de serviços de fertilidade    

Fertility Services Market Definition

Fertility services refer to a comprehensive range of medical treatments and interventions designed to assist individuals and couples in achieving pregnancy. These services include diagnostic testing to identify fertility issues, assisted reproductive technologies (ART) such as in vitro fertilization (IVF) services and intrauterine insemination (IUI), as well as fertility preservation techniques such as egg or sperm freezing. In addition, fertility services often provide counseling and support to help individuals navigate the emotional challenges associated with infertility, ultimately aiming to enhance reproductive health and facilitate family planning.

Fertility Services Market Dynamics

Drivers

• Rising Infertility Rates

Rising infertility rates among couples are a significant driver of demand for fertility services, influenced by factors such as delayed marriage, lifestyle choices, and environmental factors. According to the World Health Organization (WHO), approximately 15% of couples globally experience infertility, with the prevalence rising due to changing societal norms, where individuals often prioritize education and career before starting families. In addition, lifestyle factors, such as unhealthy diets, increased stress levels, and rising obesity rates, further contribute to fertility challenges. For instance, the American Society for Reproductive Medicine (ASRM) reports that conditions such as polycystic ovary syndrome (PCOS) and male infertility are becoming more common, exacerbating the need for assisted reproductive technologies. As couples face these challenges, the demand for fertility services continues to grow, driving innovations and expansions in the market.

• Growing Market for Egg Freezing

The growing market for egg freezing is a significant driver in the fertility services sector, reflecting changing societal norms and increasing awareness among women about their reproductive options. According to the American Society for Reproductive Medicine (ASRM), egg freezing cycles increased to 29,803, up from 24,560 in 2021. Additionally, advancements in freezing technologies, such as vitrification, have significantly improved the success rates of thawing frozen eggs, further encouraging women to consider this option. As more fertility clinics offer egg freezing services and provide educational resources, this growing awareness is likely to drive demand, making egg freezing a key component of the fertility services market, thereby driving the market growth.

Opportunities

• Increasing Awareness Regarding In Vitro Fertilization (IVF)

The increase in awareness regarding in vitro fertilization (IVF) is creating significant opportunities within the global fertility services market. As more individuals and couples become informed about the benefits of IVF, particularly in addressing infertility challenges, the demand for these services has surged. Educational initiatives, social media campaigns, and success stories shared by patients are helping to demystify the IVF process and reduce stigma surrounding fertility treatments. For instance, organizations such as the American Society for Reproductive Medicine (ASRM) provide resources and information that empower couples to make informed decisions about their reproductive health. Additionally, the rise of fertility clinics offering comprehensive services, such as egg freezing and fertility preservation, caters to the evolving needs of patients, especially those delaying parenthood for personal or professional reasons. This heightened awareness and acceptance of IVF, combined with advancements in reproductive technologies, is expected to drive significant growth in the global fertility services market, creating new opportunities for service providers and innovators in the field.

• Increasing Advancements in Genetic Testing

Advancements in technology are revolutionizing the fertility services market, particularly through innovations in assisted reproductive technologies (ART) that enhance success rates and attract a growing patient base. For instance, Advancements in genetic testing, such as preimplantation genetic testing for aneuploidy (PGT-A), allow for the screening of embryos for chromosomal abnormalities before implantation, further increasing the likelihood of successful pregnancies. As these technologies become more widely adopted, fertility clinics that integrate them into their practice can significantly improve patient outcomes and satisfaction, thus positioning themselves competitively in a rapidly evolving market. This technological evolution fosters patient trust and opens new opportunities for clinics focused on providing cutting-edge fertility solutions.

Restraints/Challenges

• High Treatment Costs

High treatment costs present a substantial challenge in the fertility services market, as the expenses associated with procedures such as In-Vitro Fertilization (IVF) and other assisted reproductive technologies can be prohibitively high for many patients. The financial burden can lead to significant stress for couples trying to conceive, especially since multiple treatment cycles are often needed for success. Furthermore, many insurance plans do not cover fertility treatments, limiting access for a considerable portion of the population. This lack of coverage disproportionately affects low- and middle-income individuals, who may be forced to make difficult decisions regarding their reproductive health. As a result, high treatment costs hinder access to essential medical care and contribute to growing disparities in reproductive health outcomes.

• Ethical Concerns Surrounding Assisted Reproductive Technologies

Ethical concerns surrounding assisted reproductive technologies (ART) represent a significant challenge in the fertility services market, as they encompass various implications related to genetic testing, embryo selection, and the use of donor gametes. For instance, the practice of embryo selection, which involves choosing embryos with the highest likelihood of successful implantation based on genetic profiling, raises questions about "designer babies" and the moral implications of selecting traits. These ethical dilemmas can create hesitancy among potential patients, as individuals may grapple with the moral considerations of their choices regarding reproduction. In addition, public backlash can arise against certain practices, leading to increased scrutiny and potential regulatory restrictions on ART. Such ethical complexities can deter individuals from seeking fertility treatments, ultimately impacting market growth and the willingness of healthcare providers to offer certain services, thereby presenting a notable challenge within the fertility services sector.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Fertility Services Market Scope

The market is segmented on the basis of infertility, procedure, services, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Diagnosis
• Male infertility
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Microscopic Examination
  • Sperm Agglutination
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others
• Female infertility
  • Ovarian reserve testing
  • Hysterosalpingography
  • Hormone testing
  • Other Tests
• Treatment
  • In-Vitro Fertilization (IVF)
  • Artificial Insemination
• Preservation
  • Egg & Embryo Freezing
  • Sperm Banking

Procedure

• Assisted Reproductive Technology (ART)
• In-Vitro Fertilization (IVF)
• Artificial Insemination
• Surrogacy
• Others

Services

• Donor services
• Non-donor services

End-User

• Fertility clinics
• Hospitals
• Clinical research institutes
• Surgical centers

Fertility Services Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, infertility, procedure, services, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the fertility services market, driven by several key factors, including declining fertility rates and a rising median age of motherhood. As more women delay childbirth for various reasons, the demand for fertility services has increased significantly. In addition, the growing prevalence of obesity in the region further contributes to fertility challenges, prompting individuals and couples to seek assisted reproductive technologies and related services to enhance their chances of conception.

Asia-Pacific region is projected to experience the highest growth rate from 2022 to 2029, driven primarily by a notable decline in fertility rates. This trend not only impacts demographic dynamics but also influences healthcare demand and resource allocation. As a result, the region's healthcare sector is expected to adapt to changing population needs and preferences, fostering innovation and investment opportunities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Fertility Services Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Fertility Services Market Leaders Operating in the Market Are:

• Olympus Corporation (Japan)
• The Cooper Companies Inc. (U.S.)
• Instituto Bernabeu (Spain)
• VirtusHealth (Australia)
• CooperSurgical, Inc. (U.S.)
• Vitrolife (Sweden)
• Care Fertility (U.K.)
• INVO Bioscience (U.S.)
• Monash IVF (Australia)
• Fertility Focus Limited (U.S.)
• Carolinas Fertility Institute (U.S.)
• Apollo Hospitals Enterprise Ltd. (India)
• Merck KGaA (Germany)
• LABOTECT GMBH (Germany)
• Medicover AB (Sweden)

Latest Developments in Fertility Services Market

• In June 2023, Quantum Health formed a partnership with Progyny, Inc. to launch Quantum Health's Comprehensive Care Solutions platform, specifically designed to provide family building and fertility solutions. This collaboration aims to enhance access to fertility services, offering a streamlined approach to care that supports individuals and couples on their journey to parenthood
• In April 2023, Cryoport, Inc. entered into a three-year supply chain agreement with Boston IVF to facilitate the shipment of reproductive materials across the United States. This partnership is intended to ensure the safe and timely transport of critical biological samples, such as eggs, sperm, and embryos, which are essential for fertility treatments
• In October 2022, Maven Clinic, a U.S.-based company specializing in telemedicine and virtual clinic services for women’s and family health, partnered with Indira IVF, an India-based infertility specialty clinic chain. This collaboration aims to extend access to Indira IVF's high-quality clinical care to Maven's members in India, enhancing the support available for family-building needs
• Em julho de 2021, a Hamilton Throne Ltd., fornecedora global de investigação ART, adquiriu a IVFTECH ApS (IVFtech) e a sua empresa afiliada, K4 Technology ApS. Esta aquisição reforça o compromisso da IVFtech em fornecer estações de trabalho de fluxo laminar e incubadoras de grande capacidade para tecnologia de reprodução assistida (ART), aproveitando os recursos e a experiência da K4 Technology. Juntos, visam melhorar a qualidade e a eficiência das soluções ART na indústria
• Em maio de 2021, a Virtus Health, líder global em serviços de reprodução assistida (ARS), anunciou uma parceria estratégica com a Drop Bio, uma empresa australiana de biotecnologia e saúde digital especializada em inflamação crónica. Esta colaboração visa melhorar os avanços na fertilidade de precisão, aproveitando a experiência de ambas as empresas para melhorar os resultados de fertilidade e adaptar os tratamentos às necessidades individuais dos pacientes.
• Em junho de 2020, a Ferring BV e a Igenomix estabeleceram uma colaboração de investigação de quatro anos focada no desenvolvimento de produtos terapêuticos inovadores para o tratamento de condições relacionadas com a gravidez. Esta parceria combina a experiência da Ferring em medicina reprodutiva com as capacidades de análise genética de ponta da Igenomix

SKU-29201